DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors

Mauro Cives, Stefano Partelli, Raffaele Palmirotta, Domenica Lovero, Barbara Mandriani, Davide Quaresmini, Eleonora Pelle’, Valentina Andreasi, Paola Castelli, Jonathan Strosberg, Giuseppe Zamboni, Massimo Falconi, Franco Silvestris

Research output: Contribution to journalArticle

Abstract

Management of localized well-differentiated pancreatic neuroendocrine tumors (panNETs) is controversial and primarily dependent on tumor size. Upfront surgery is usually recommended for tumors larger than 2 cm in diameter since they frequently show metastatic potential, whereas smaller panNETs are generally characterized by an indolent clinical course, with a rate of relapse or metastasis below 15%. To explore whether increased tumor size is paralleled by genomic variations, we compared the rate and the mutational patterns of putative driver genes that are recurrently altered in these tumors by investigating differential cohorts of panNET surgical specimens smaller (n = 27) or larger than 2 cm (n = 29). We found that the cumulative number of mutations detected in panNETs >2 cm was significantly higher (p = 0.03) relative to smaller tumors, while mutations of DAXX were significantly more frequent in the cohort of larger tumors (p = 0.05). Moreover, mutations of DAXX were associated with features of malignancy including increased grade, nodal involvement and lymphovascular invasion, and independently predicted both relapse after surgery (p = 0.05) and reduced DFS in multivariable analysis (p = 0.02). Our data suggest that alterations of the DAXX/ATRX molecular machinery increase the malignant potential of panNETs, and that identification of mutations of DAXX/ATRX in small, nonfunctioning tumors can predict the malignant progression observed in a minority of them.

Original languageEnglish
Article number18614
JournalScientific Reports
Volume9
Issue number1
DOIs
Publication statusPublished - Dec 1 2019

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors'. Together they form a unique fingerprint.

  • Cite this

    Cives, M., Partelli, S., Palmirotta, R., Lovero, D., Mandriani, B., Quaresmini, D., Pelle’, E., Andreasi, V., Castelli, P., Strosberg, J., Zamboni, G., Falconi, M., & Silvestris, F. (2019). DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors. Scientific Reports, 9(1), [18614]. https://doi.org/10.1038/s41598-019-55156-0